Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study

References

• van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367. doi:10.1056/NEJMoa011300
   PubMed Web of Science ®Google Scholar
• Lanspa MJ, Dickerson J, Morris AH, Orme JF, Holmen J, Hirshberg EL. Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin. Crit Care. 2014;18:R86. doi:10.1186/cc13851
   PubMedGoogle Scholar
• Mahmoodpoor A, Hamishehkar H, Beigmohammadi M, et al. Predisposing factors for hypoglycemia and its relation with mortality in critically ill patients undergoing insulin therapy in an intensive care unit. Anesth Pain Med. 2016;6:e33849. doi:10.5812/aapm.
   PubMedGoogle Scholar
• Mahmoodpoor A, Hamishehkar H, Shadvar K, Beigmohammadi M, Iranpour A, Sanaie S. Relationship between glycated hemoglobin, intensive care unit admission blood sugar and glucose control with ICU mortality in critically ill patients. Indian J Crit Care Med. 2016;20:67–71. doi:10.4103/0972-5229.175938
   PubMedGoogle Scholar
• Samarkandy SJ, Al-Dorzi HM, Tamim HM, Arabi YM. Nursing workload and perception about intensive insulin therapy in critically ill adult patients. Saudi Med J. 2010;31:331–332.
   PubMedGoogle Scholar
• Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251–3276. doi:10.1097/CCM.0b013e3182653269
   PubMed Web of Science ®Google Scholar
• Vercoza Viana M, Vercoza Viana L, Tavares AL, de Azevedo MJ. Insulin regimens to treat hyperglycemia in hospitalized patients on nutritional support: systematic review and meta-analyses. Ann Nutr Metab. 2017;71:183–194. doi:10.1159/000481355
   PubMedGoogle Scholar
• Ciardullo AV, Bacchelli M, Daghio MM, Carapezzi C. Effectiveness and safety of insulin glargine in the therapy of complicated or secondary diabetes: clinical audit. Acta Diabetol. 2006;43:57–60. doi:10.1007/s00592-006-0213-7
   PubMedGoogle Scholar
• Doshi P, Potter AJ, De Los Santos D, Banuelos R, Darger BF, Chathampally Y. Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study. Acad Emerg Med. 2015;22:657–662. doi:10.1111/acem.12673
   PubMedGoogle Scholar
• Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011;94:340–351. doi:10.1016/j.diabres.2011.09.012
   PubMed Web of Science ®Google Scholar
• Shankar V, Haque A, Churchwell KB, Russell W. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Intensive Care Med. 2007;33:1173–1178. doi:10.1007/s00134-007-0674-3
   PubMedGoogle Scholar
• Willis GJ, Fisk L, Razak N, Le Compte A, Shaw GM, Chase JG. Insulin glargine in the intensive care unit: A model-based clinical trial design. Biomed Signal Process Control. 2013;8:120–129.
   Google Scholar
• Datta S, Qaadir A, Villanueva G, Baldwin D. Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial. Endocr Pract. 2007;13:225–231. doi:10.4158/EP.13.3.225
   PubMedGoogle Scholar
• Andrade-Castellanos CA, Colunga-Lozano LE. [Systematic review with meta-analysis: subcutaneous insulin glargine coadministration for diabetic ketoacidosis]. Gac Med Mex. 2016;152:761–769. Spanish.
   PubMedGoogle Scholar
• Houshyar J, Bahrami A, Aliasgarzadeh A. Effectiveness of insulin glargine on recovery of patients with diabetic ketoacidosis: a randomized controlled trial. J Clin Diagn Res. 2015;9:OC01–5. doi:10.7860/JCDR/2015/12005.5883
   PubMedGoogle Scholar
• Yeldandi RR, Lurie A, Baldwin D. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery. Diabetes Technol Ther. 2006;8:609–616. doi:10.1089/dia.2006.8.609
   PubMed Web of Science ®Google Scholar
• Bhurayanontachai R, Rattanaprapat T, Kongkamol C. Comparison of glycemic control between continuous regular insulin infusion and single-dose subcutaneous insulin glargine injection in medical critically ill patients. Indian J Crit Care Med. 2018;22:174–179. doi:10.4103/ijccm.IJCCM_273_17
   PubMed Web of Science ®Google Scholar
• Ergin AB, Nasr G, Yared JP, Bena J, Nasr C. Glycemic control with use of insulin glargine after cardiothoracic surgery: a retrospective study. Endocr Pract. 2013;19:485–493. doi:10.4158/EP12404.OR
   PubMedGoogle Scholar
• Oghazian MB, Javadi MR, Radfar M, et al. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial. Pharmacotherapy. 2015;35:148–157. doi:10.1002/phar.2015.35.issue-2
   PubMedGoogle Scholar
• Hakeam HA, Mulia HA, Azzam A, Amin T. Glargine insulin use versus continuous regular insulin in diabetic surgical noncritically ill patients receiving parenteral nutrition: randomized controlled study. JPEN J Parenter Enteral Nutr. 2017;41:1110–1118. doi:10.1177/0148607116644710
   PubMedGoogle Scholar
• Masse J, Giuliano CA, Brown S, Paxton RA. Association between the use of long-acting insulin and hypoglycemia in nondiabetic patients in the surgical intensive care unit. J Intensive Care Med. 2018;33:317–321. doi:10.1177/0885066616677030
   PubMedGoogle Scholar
• Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35:2262–2267. doi:10.1097/01.CCM.0000282073.98414.4B
   PubMed Web of Science ®Google Scholar